December 09, 2020
Victor G Vogel, MD, medical oncologist, Geisinger Health System, discusses a variety of risk reducing strategies for breast cancer, including why some are “overdue,” explains why there is a lack in the uptake of medications among patients despite national and global organization support for these treatments, and offers suggestions on what payers can do to help address issues relating to the cost of treatment.
Vogel VG. Implementation of risk reducing strategies for breast cancer is long overdue [published online ahead of print, 2020 Nov 11]. Cancer Prev Res (Phila). 2020;canprevres.0556.2020. doi:10.1158/1940-6207.CAPR-20-0556